PROTHYA BIOSOLUTIONS
DEAD

Serial Number

79338756

Owner

Sanquin Plasma Products B.V.

Attorney

THOMAS J. MANGO

Filing Date

Oct 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PROTHYA BIOSOLUTIONS Trademark

Serial Number: 79338756

PROTHYA BIOSOLUTIONS is a trademark filed by Sanquin Plasma Products B.V. on October 18, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Sanquin Plasma Products B.V. (2 trademarks)

Plesmanlaan 125

Entity Type: 99

Trademark Details

Filing Date

October 18, 2021

Registration Date

Not Registered

Published for Opposition

December 5, 2023

Goods & Services

Advertising services; advertising and promotional services for others relating in particular to blood plasma, blood, blood products and components in the nature of blood plasma, blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, globular proteins, human blood plasma, fractionated human blood plasma, all for medical use and blood bank services, medical laboratory services, blood-supply organization services, namely, the collection and testing of blood, the development, preparation and testing of blood products, blood intermediate products, blood components, blood samples, plasma and plasma products; consultancy and advisory services relating to business management for blood banks and blood-supply organizations; business assistance with the management of commercial affairs; wholesale and retail store services relating to blood plasma, blood, blood products and components in the nature of blood plasma, blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, globular proteins, human blood plasma, fractionated human blood plasma, all for medical use; import-export agency services; promoting public awareness of the need for blood donations by recruiting blood donors for others; all aforementioned services also provided via the internet

Blood plasma, whole blood, blood products and components in the nature of blood plasma for medical purposes; blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, human blood plasma, fractionated human blood plasma, all for medical use

Blood bank services; medical laboratory services, relating to the preparation and maintenance of tissues, blood plasma and related products; blood-supply organization services, namely, the collection and testing of blood, the development, preparation and testing of blood products, blood intermediate products, blood components, blood samples, plasma and plasma products; consultancy and advisory services relating to blood banks and blood-supply organizations; all the foregoing services also being provided via the internet

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Mar 11, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 11, 2026 FICR
REFUSAL PROCESSED BY IB
May 9, 2025 RFNP
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 11, 2025 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 11, 2025 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 11, 2025 OP.T
OPPOSITION SUSTAINED NO. 999999
Mar 11, 2025 OP.S
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 7, 2025 OPNS
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 13, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Jun 13, 2024 OP.I
OPPOSITION PAPERS RECEIVED AT TTAB
Jun 10, 2024 OPPF
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 4, 2024 RFCR
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jun 4, 2024 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 21, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 3, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 15, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 15, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 18, 2023 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 27, 2023 OPNR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Sep 12, 2023 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Sep 12, 2023 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Sep 12, 2023 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 22, 2023 GNFN
FINAL REFUSAL E-MAILED
May 22, 2023 GNFR
FINAL REFUSAL WRITTEN
May 22, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2023 TROA
REFUSAL PROCESSED BY IB
Nov 8, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 17, 2022 RFCS
REFUSAL PROCESSED BY MPU
Oct 17, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 24, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 23, 2022 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 22, 2022 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2022 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Jul 11, 2022 LOPT
APPLICATION FILING RECEIPT MAILED
May 3, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2022 REPR